Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus

被引:38
作者
Adebisi, Adeola O. [1 ]
Conway, Barbara R. [1 ]
机构
[1] Univ Huddersfield, Dept Pharm, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England
关键词
Helicobacter pylori; Microspheres; Ethylcelluose; Chitosan; Concanavalin A; Mucoadhesive; DRUG-DELIVERY; MUCOADHESIVE MICROSPHERES; TOMATO LECTIN; CLARITHROMYCIN; MICROPARTICLES; RELEASE; STABILITY; SYSTEM; BIOADHESION; ABSORPTION;
D O I
10.1016/j.ijpharm.2014.04.070
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Using second generation mucoadhesives may enhance targeting antibiotics for eradication of Helicobacter pylori from the stomach for the treatment of peptic ulcer. The aim of this research was to prepare and characterise ethylcellulose/chitosan microspheres containing clarithromycin with their surfaces functionalised with concanavalin A to produce a floating-mucoadhesive formulation. The microspheres were prepared using an emulsification-solvent evaporation method. Particle size, surface morphology, in vitro buoyancy profile, zeta potential, drug entrapment efficiency, in vitro drug release and release kinetics of the particles were determined. Lectin was conjugated to the microsphere surface using two-stage carbodiimide activation and confirmed using FTIR, fluorescence studies and zeta potential measurements. Conjugation ranged from 11 to 15 mu g Con A/mg microspheres which represents over 56% efficiency although there was some drug loss during the conjugation process. Conjugation did not have a significant effect on the buoyancy and release of drug from the microspheres using a mucus diffusion model with 53% and 40% of drug released from unconjugated and conjugated microspheres within 12 h. Conjugation improved mucoadhesion and interaction with porcine gastric mucin compared to unconjugated microspheres. The buoyancy and improved mucoadhesion of the microspheres provides potential for delivery of clarithromycin and other drugs to the stomach. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:28 / 40
页数:13
相关论文
共 63 条
  • [1] Gastroretentive microparticles for drug delivery applications
    Adebisi, Adeola
    Conway, Barbara R.
    [J]. JOURNAL OF MICROENCAPSULATION, 2011, 28 (08) : 689 - 708
  • [2] Mucoadhesive drug delivery systems
    Shaikh, Rahamatullah
    Singh, Thakur Raghu Raj
    Garland, Martin James
    Woolfson, A. David
    Donnelly, Ryan F.
    [J]. JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2011, 3 (01): : 89 - 100
  • [3] Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites
    Akiyama, Y
    Nagahara, N
    Nara, E
    Kitano, M
    Iwasa, S
    Yamamoto, I
    Azuma, J
    Ogawa, Y
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (02) : 159 - 166
  • [4] Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate
    Anande, Nalini M.
    Jain, Sunil K.
    Jain, Narendra K.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 359 (1-2) : 182 - 189
  • [5] BARONDES SH, 1994, J BIOL CHEM, V269, P20807
  • [6] Batchelor HK, 2007, ADV DRUG FORMULATION, P217
  • [7] Treatment of Helicobacter pylori infection.: Indications and regimens:: an update
    Bazzoli, F
    Porro, GB
    Maconi, G
    Molteni, M
    Pozzato, P
    Zagari, RM
    [J]. DIGESTIVE AND LIVER DISEASE, 2002, 34 (01) : 70 - 83
  • [8] Mucoadhesive drug delivery system: An overview
    Boddupalli, Bindu M.
    Mohammed, Zulkar N. K.
    Nath, Ravinder A.
    Banji, David
    [J]. JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2010, 1 (04) : 381 - 387
  • [9] Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection
    Cammarota, G.
    Sanguinetti, M.
    Gallo, A.
    Posteraro, B.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (03) : 222 - 230
  • [10] Mucoadhesive microspheres for controlled drug delivery
    Chowdary, KPR
    Rao, YS
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (11) : 1717 - 1724